James Michael O'Brien - 07 Jul 2026 Form 4 Insider Report for MESOBLAST LTD (MESO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Jul 2026, 21:54:11 UTC
Prior SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James Michael O'Brien

Key filing fact

James Michael O'Brien filed Form 4 for MESOBLAST LTD (MESO) on 09 Jul 2026.

Key facts

  • This page summarizes James Michael O'Brien's Form 4 filing for MESOBLAST LTD (MESO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 09 Jul 2026, 21:54.

Change

  • Previous filing in this sequence was filed on 18 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002120836 Primary reporting owner

OBRIEN JAMES MICHAEL

Relationship
Chief Financial Officer
Address
LEVEL 38, 55 COLLINS STREET, MELBOURNE, AUSTRALIA
Signature
/s/ James Michael O'Brien
Signature date
09 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MESO transaction Derivative

Option (Right to buy)

Award

Transaction value
Shares
+650,000
Change %
Price
$0.000000*
Shares after
650,000
Date
23 Dec 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
650,000
Exercise price
$2.90
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The exercise price for options is in Australian dollars.

Footnote F2

Granted on December 23, 2025. Vesting is dependent on Mr. O'Brien achieving certain milestones

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .